Search

everythinglearnresearchcommunity

for

Search:↓

Clinicians should consider individual factors and communicate risks and benefits when prescribing ritlecitinib for adolescent alopecia areata.

Over half of alopecia areata patients in Tunisia experience depression, highlighting the need for psychological support.

Changes in skin bacteria may relate to alopecia areata severity.

Alopecia areata significantly affects patients' lives, causing physical, psychological, social, and financial challenges.

Continuous baricitinib is needed to keep hair regrowth in severe alopecia areata.

A change in SALT scores of 42 or 43 indicates meaningful improvement in alopecia areata treatment.

Severe alopecia areata greatly impacts quality of life, mental health, and daily activities.

Patients with rheumatoid arthritis using tofacitinib had more serious side effects than those with alopecia areata.

Patients were highly satisfied with shared medical appointments for hair loss treatment.

Tofacitinib is a safe treatment for hair loss in children, but long-term use may be needed for best results.

Current treatments for Alopecia Areata don't fully meet patients' needs, indicating a need for better therapies.

Combining baricitinib with golimumab helped regrow hair in a patient with ankylosing spondylitis and alopecia areata.

DPCP immunotherapy is effective for alopecia areata, and understanding influencing factors can improve treatment and satisfaction.

Baricitinib effectively and safely improves hair growth in patients with severe alopecia areata.

Reducing the dose of Baricitinib to 2mg still helped over half of the patients with severe scalp alopecia maintain their hair regrowth after two years.

Tofacitinib is effective and has minor, reversible side effects for treating severe hair loss in Iran.

Patients with severe alopecia areata felt better and less anxious or depressed when treated with baricitinib compared to placebo.

Comprehensive screening for infections is crucial before starting JAK inhibitors in alopecia areata patients.

CTP-543 significantly improved eyebrow and eyelash regrowth and patient satisfaction in adults with alopecia areata.

People with alopecia areata may have a higher risk of blood clots.

Early diagnosis and treatment of alopecia areata in children is crucial to prevent severe progression.

Histopathological examination is essential for diagnosing alopecia areata.

Tofacitinib effectively treated severe hair loss in a patient who didn't respond to other treatments.

There's no strong link between Alopecia Areata, a hair loss condition, and fatty liver, but more research is needed.

Tofacitinib helped regrow hair in most patients with severe hair loss.

Ritlecitinib helped most alopecia areata patients regrow hair by Week 48.

Trichloroacetic acid is a safe and effective treatment for hair loss in alopecia areata patients.

Patients with a specific genetic variant have more severe alopecia areata and higher recurrence rates.

There's no link between low iron levels and the hair loss condition, alopecia areata.

Screening for iron levels in patients with hair loss may help find a genetic iron overload condition early.